ArticleFrontiers in public health2026
Beyond metrics: relational dynamics and impacts of TB community funding.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Global funding for tuberculosis (TB) falls far short of estimated needs, often prioritizing commodities and service delivery. TB communities, including people affected by TB, remain underfunded and underrepresented in programme planning. Despite this TB-affected communities have, over the past decade, driven significant progress in becoming recognized actors in national and global TB responses. These gains have been largely supported by the Stop TB Partnership Challenge Facility for Civil Society (CFCS), a funding mechanism which supports people affected by TB and community organizations and their partnerships with National TB Programmes. This model now faces a critical funding shortage. This analysis draws on final reports from 99 country-specific projects funded under CFCS 12 (2023-2025). In final reporting partners responded to three open-ended reflection questions on unexpected impacts, challenges, and lessons learned in. Responses were analyzed inductively using NVivo 12, with themes iteratively developed. Three key relational themes emerged. First, TB stigma was reported not only as a barrier to care but also as an operational barrier to programme delivery. Second, the value of meaningful community engagement and collaboration were identified as the most important lesson from programme implementation. Third, expanded recognition and influence were the most important unexpected outcome of programme delivery. These reflections highlight the relational challenges and value of TB community funding, directing us to consider what is included in funding considerations and project planning, while also pointing toward how much-beyond programmatic outcomes-will be lost if funding is reduced further.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.